Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Rituximab Reduces Immunogenicity and Increases Complete Remissions without Minimal Residual Disease in Relapsed/Refractory Hairy Cell Leukemia Patients Receiving Moxetumomab Pasudotox

Robert J. Kreitman, Constance M. Yuan, Hao-Wei Wang, Hong Zhou, Mark Raffeld, Liqiang Xi, Evgeny Arons, Julie Feurtado, Lacey James, Raul C. Braylan, Katherine R. Calvo, Irina Maric, Ira Pastan

Blood (2024) 144 (Supplement 1): 6791.

https://doi.org/10.1182/blood-2024-199569

Published: 2024

Journal Articles

A Randomized Phase 2 Trial of 2nd-Line Cladribine with Concurrent or Delayed Rituximab in Patients with Classic Hairy Cell Leukemia

Robert J. Kreitman, Hao-Wei Wang, Dana I. Delgado Colon, Hong Zhou, Evgeny Arons, Mark Raffeld, Liqiang Xi, Julie Feurtado, Lacey James, Raul C. Braylan, Katherine R. Calvo, Irina Maric, Constance M. Yuan

Blood (2024) 144 (Supplement 1): 863.

https://doi.org/10.1182/blood-2024-202793

Published: 2024

Journal Articles

Non-V600E BRAF Gene Alterations in Hairy Cell Leukemia

Evgeny Arons, Chin-Hsien Tai, Suraj Joshi, Yuelin Liu, Chi-ping Day, Mark Raffeld, Liqiang Xi, Hong Zhou, Mory Gould, Isaac Shpilman, Christopher C. Oakes, Seema A Bhat, Michael R. Grever, Kerry A. Rogers, Hao-Wei Wang, Constance M. Yuan, Cenk Sahinalp, Robert J. Kreitman

Blood (2024) 144 (Supplement 1): 1586.

https://doi.org/10.1182/blood-2024-204016

Published: 2024

Journal Articles

Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia Variant

Dai Chihara, MD PhD, Evgeny Arons, PhD, Maryalice Stetler-Stevenson, MD PhD, Constance M. Yuan, MD PhD, Hao-Wei Wang, MD PhD, Hong Zhou, Mark Raffeld, MD, Liqiang Xi, MD, Seth M. Steinberg, PhD, Julie Feurtado, RN, Lacey James-Echenique, CRNP, Wyndham Wilson, MD, Raul C. Braylan, MD, Katherine R. Calvo, MD PhD, Irina Maric, MD MSci, Alina Dulau-Florea, MD, Robert J. Kreitman, MD

Blood (2019) 134 (Supplement_1): 1536.

https://doi.org/10.1182/blood-2019-124515

Published: 2019

Journal Articles

Molecular Remissions with Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox Are Associated with Improved Complete Remission Durations during Phase I and III Testing

Evgeny Arons, PhD, Daniel Gorelik, Maryalice Stetler-Stevenson, MD PhD, Constance M. Yuan, MD PhD, Mark Sokolsky, Hong Zhou, Nai Shun (nancy) Yao, MD, Shannon Marshall, PhD, Katherine Potocka, Erin Fykes, Ira Pastan, MD, Robert J. Kreitman, MD

Blood (2018) 132 (Supplement 1): 1861.

https://doi.org/10.1182/blood-2018-99-113419

Published: 2018

Journal Articles

Increased Expression of Myc in Hairy Cell Leukemia, and Cell-Sensitivity to JQ1

Evgeny Arons, PhD, Hong Zhou, Yonghong Wang, PhD, Daniel Edelman, PhD, Robert J. Kreitman, MD, Holly S Stevenson, Josh J Waterfall, PhD, Paul S. Meltzer, MD PhD

Blood (2016) 128 (22): 5112.

https://doi.org/10.1182/blood.V128.22.5112.5112

Published: 2016

Journal Articles

Molecular Evidence of Ongoing Antigen Driven Somatic Hypermutation in the Natural History of Classic and Variant Hairy Cell Leukemia

Evgeny Arons, PhD, Sarah Davies, Katherine Still, Nathan Chai, Katherine Potocka, Hong Zhou, Robert J. Kreitman, MD

Blood (2015) 126 (23): 2648.

https://doi.org/10.1182/blood.V126.23.2648.2648

Published: 2015

Journal Articles

Interim Results of a Multi-Center Observational Study of Current Treatment Patterns for Patients with Severe Aplastic Anemia (SAA), Very Severe Aplastic Anemia (VSAA) and Transfusion-Dependent Non-Severe Aplastic Anemia (TD-NSAA) in China

Blood (2015) 126 (23): 4505.

https://doi.org/10.1182/blood.V126.23.4505.4505

Published: 2015

Journal Articles

Minimal Residual Disease By Patient-Specific Taqman Real Time PCR in Newly Diagnosed Hairy Cell Leukemia Patients Randomized to Initial Vs Delayed Rituximab in Combination with Cladribine

Evgeny Arons, PhD, Katherine Still, BS, Sarah Davies, BS, Hong Zhou, BS, Robert J. Kreitman, MD

Blood (2014) 124 (21): 1747.

https://doi.org/10.1182/blood.V124.21.1747.1747

Published: 2014

Journal Articles

CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine

Ying Gu, Ting Chen, Zhipeng Meng, Yichao Gan, Xiaohua Xu, Guiyu Lou, Hongzhi Li, Xiaoxian Gan, Hong Zhou, Jinfen Tang, Genbo Xu, Liansheng Huang, Xiaohong Zhang, Yongming Fang, Kai Wang, Shu Zheng, Wendong Huang, Rongzhen Xu

Blood (2012) 120 (24): 4829–4839.

https://doi.org/10.1182/blood-2012-06-434894

Published: 2012

Includes: Supplemental data

Journal Articles

Inducible Costimulator Gene Transduced Bone Marrow Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in a Mouse Haploidentical Model.

Dan Yang, Jian-Min Wang, Sr., M.D, Li-ping Wang, Hong Zhou

Blood (2012) 120 (21): 2996.

https://doi.org/10.1182/blood.V120.21.2996.2996

Published: 2012

Journal Articles

Resolution of Hairy Cell Leukemia Minimal Residual Disease by Both BRAF and Clone-Specific Real-Time Quantitative PCR (RQ-PCR) After Treatment with Moxetumomab Pasudotox.

Robert J. Kreitman, MD, Evgeny Arons, PhD, Sapolsky Jeffrey, Laura Roth, Hong Zhou, BS, Maryalice Stetler-Stevenson, MD, PhD, Wyndham H. Wilson, MD, PhD, Mark Raffeld, MD, David J. P. FitzGerald, PhD, Ji Fei, PhD, Ramy Ibrahim, MD, Ira Pastan, MD

Blood (2012) 120 (21): 2896.

https://doi.org/10.1182/blood.V120.21.2896.2896

Published: 2012

Journal Articles

Interim Results of Secondary Endpoints From a Randomized Trial of Cladribine with Early Vs Delayed Rituximab for Treatment of Early Hairy Cell Leukemia

Robert J Kreitman, MD, Wyndham H. Wilson, MD, PhD, Hong Zhou, BS, Mark Raffeld, MD, Maryalice Stetler-Stevenson, MD, PhD, Evgeny Arons, PhD

Blood (2011) 118 (21): 2856.

https://doi.org/10.1182/blood.V118.21.2856.2856

Published: 2011

Journal Articles

F-627, a G-CSF Dimer, Stimulated a More Rapid Neutrophil Recovery In Cyclophosphamide-Treated Monkeys Compared to Monomer Rhg-CSFs.

Zheng Tao Hu, Ph.D., Zhi Hua Huang, Xiao Bo Cen, Ph.D., Tao Wang, Ph.D., Kun Zhuang, Hong Zhou Yang, Dan Ping Zhang, Nai Chau Sun, Rou Yun Sun, Li Wang, Yu Liang Huang, Ph.D., Xiao Qiang Yan, Ph.D.

Blood (2010) 116 (21): 1485.

https://doi.org/10.1182/blood.V116.21.1485.1485

Published: 2010

Journal Articles

Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival

Grace H. Ku, Richard H. White, Helen K. Chew, Danielle J. Harvey, Hong Zhou, Ted Wun

Blood (2009) 113 (17): 3911–3917.

https://doi.org/10.1182/blood-2008-08-175745

Published: 2009

Journal Articles

Amplification and Mutation of PSMB5 Gene in Bortezomib Resistant Lymphoblastic Leukemia Cells Derived from Jurkat Line.

Shuqing Lu, MD, PhD, Jianmin Wang, MD, Jianmin Yang, MD/Ph.D, Shenglan Gong, MD, Hong Zhou, MD, Li Chen, MD/Ph.D, Xianmin Song, MD/Ph.D

Blood (2007) 110 (11): 2373.

https://doi.org/10.1182/blood.V110.11.2373.2373

Published: 2007

Journal Articles

Incidence of Venous Thromboembolism in Patients with Acute Leukemia.

Grace Ku, MD, Richard H. White, MD, Helen K. Chew, MD, Danielle Harvey, PhD, Hong Zhou, PhD, Ted Wun, MD

Blood (2006) 108 (11): 1497.

https://doi.org/10.1182/blood.V108.11.1497.1497

Published: 2006

Journal Articles

Cause of Death among Patients with Local or Regional Stage Cancer of the Breast, Colon and Lung Who Develop Venous Thromboembolism (VTE).

Ted Wun, MD, Helen K. Chew, MD, Hong Zhou, PhD, Danielle Harvey, PhD, Richard H. White, MD

Blood (2006) 108 (11): 1501.

https://doi.org/10.1182/blood.V108.11.1501.1501

Published: 2006

Journal Articles

The Etiological Analysis of 100 Case of Aged and Non-Hematological Hospitalized Anemia in Southen China.

Zhisheng Jiang, MD, Chunna He, MD, Hong Zhou, MD, Qing Wang, MD, Da Li, MD, Bing Liang, MD

Blood (2005) 106 (11): 3719.

https://doi.org/10.1182/blood.V106.11.3719.3719

Published: 2005

Journal Articles

Reduced-Intensity Conditioning Versus Conventional Regimen for Allogeneic Peripheral Blood Hematopoietic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia.

Jianmin Wang, MD, Weiping Zhang, MD, Caobo Feng, MD, Xianmin Song, MD, Xiong Ni, MD, Xiaoxia Hu, BS, Lei Gao, MS, Hong Zhou, BS, Hongmei Li, BS, Xiaoqin Ding, BS

Blood (2005) 106 (11): 5299.

https://doi.org/10.1182/blood.V106.11.5299.5299

Published: 2005

NARROW

Rituximab Reduces Immunogenicity and Increases Complete Remissions without Minimal Residual Disease in Relapsed/Refractory Hairy Cell Leukemia Patients Receiving Moxetumomab Pasudotox

A Randomized Phase 2 Trial of 2nd-Line Cladribine with Concurrent or Delayed Rituximab in Patients with Classic Hairy Cell Leukemia

Non-V600E BRAF Gene Alterations in Hairy Cell Leukemia

Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia Variant

Molecular Remissions with Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox Are Associated with Improved Complete Remission Durations during Phase I and III Testing

Increased Expression of Myc in Hairy Cell Leukemia, and Cell-Sensitivity to JQ1

Molecular Evidence of Ongoing Antigen Driven Somatic Hypermutation in the Natural History of Classic and Variant Hairy Cell Leukemia

Interim Results of a Multi-Center Observational Study of Current Treatment Patterns for Patients with Severe Aplastic Anemia (SAA), Very Severe Aplastic Anemia (VSAA) and Transfusion-Dependent Non-Severe Aplastic Anemia (TD-NSAA) in China

Minimal Residual Disease By Patient-Specific Taqman Real Time PCR in Newly Diagnosed Hairy Cell Leukemia Patients Randomized to Initial Vs Delayed Rituximab in Combination with Cladribine

CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine

Inducible Costimulator Gene Transduced Bone Marrow Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in a Mouse Haploidentical Model.

Resolution of Hairy Cell Leukemia Minimal Residual Disease by Both BRAF and Clone-Specific Real-Time Quantitative PCR (RQ-PCR) After Treatment with Moxetumomab Pasudotox.

Interim Results of Secondary Endpoints From a Randomized Trial of Cladribine with Early Vs Delayed Rituximab for Treatment of Early Hairy Cell Leukemia

F-627, a G-CSF Dimer, Stimulated a More Rapid Neutrophil Recovery In Cyclophosphamide-Treated Monkeys Compared to Monomer Rhg-CSFs.

Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival

Amplification and Mutation of PSMB5 Gene in Bortezomib Resistant Lymphoblastic Leukemia Cells Derived from Jurkat Line.

Incidence of Venous Thromboembolism in Patients with Acute Leukemia.

Cause of Death among Patients with Local or Regional Stage Cancer of the Breast, Colon and Lung Who Develop Venous Thromboembolism (VTE).

The Etiological Analysis of 100 Case of Aged and Non-Hematological Hospitalized Anemia in Southen China.

Reduced-Intensity Conditioning Versus Conventional Regimen for Allogeneic Peripheral Blood Hematopoietic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only